Novel |
NSD1 |
nuclear receptor binding SET domain protein 1 |
- PKMTs methylate histone lysines
|
|
- Beckwith-Wiedemann syndrome
- Sotos syndrome and Weaver syndrome
|
|
ACTA1 |
actin alpha 1, skeletal muscle |
- Striated Muscle Contraction
|
- Latrunculin A
- Sucrose
- Ulapualide A
- Kabiramide C
- Jaspisamide A
- Tmr
- 1-Methylhistidine
- Phosphoaminophosphonic Acid-Adenylate Ester
- Aplyronine A
- Reidispongiolide A
- Reidispongiolide C
- Sphinxolide B
- Latrunculin B
|
- Congenital fiber type disproportion (CFTD)
- Cap myopathy
- Nemaline myopathy
|
|
ACTA2 |
actin alpha 2, smooth muscle |
- Smooth Muscle Contraction
- NOTCH4 Intracellular Domain Regulates Transcription
|
|
- Familial thoracic aortic aneurysm and dissection (TAAD); Aortic aneurysm familial thoracic type (AAT)
|
|
ACTB |
actin beta |
- Translocation of SLC2A4 (GLUT4) to the plasma membrane
- Gap junction degradation
- Formation of annular gap junctions
- Regulation of actin dynamics for phagocytic cup formation
- Regulation of actin dynamics for phagocytic cup formation
- HATs acetylate histones
- Prefoldin mediated transfer of substrate to CCT/TriC
- Folding of actin by CCT/TriC
- EPHB-mediated forward signaling
- EPH-ephrin mediated repulsion of cells
- Adherens junctions interactions
- Adherens junctions interactions
- Recycling pathway of L1
- Recycling pathway of L1
- VEGFA-VEGFR2 Pathway
- Interaction between L1 and Ankyrins
- Interaction between L1 and Ankyrins
- Cell-extracellular matrix interactions
- B-WICH complex positively regulates rRNA expression
- RHO GTPases activate IQGAPs
- RHO GTPases Activate WASPs and WAVEs
- RHO GTPases Activate WASPs and WAVEs
- RHO GTPases Activate Formins
- RHO GTPases Activate Formins
- MAP2K and MAPK activation
- UCH proteinases
- DNA Damage Recognition in GG-NER
- Signaling by moderate kinase activity BRAF mutants
- Signaling by high-kinase activity BRAF mutants
- Signaling by BRAF and RAF fusions
- Paradoxical activation of RAF signaling by kinase inactive BRAF
- Clathrin-mediated endocytosis
- Signaling downstream of RAS mutants
- Signaling by RAF1 mutants
- FCGR3A-mediated phagocytosis
- FCGR3A-mediated phagocytosis
- Factors involved in megakaryocyte development and platelet production
|
- Quercetin
- Phenethyl Isothiocyanate
|
- Other phagocyte defects, including the following eight diseases: Chediak-Higashi syndrome; Griscelli syndrome, type 1 (GS1); Griscelli syndrome, type 2 (GS2); Griscelli syndrome, type 3 (GS3); beta-actin deficiency; Neutrophil-specific granule deficiency; Myeloperoxidase deficiency; Glucose 6-phosphate dehydrogenase deficiency; Shwachman syndrome
|
|
ADAM9 |
ADAM metallopeptidase domain 9 |
|
|
- Cone-rod dystrophy and cone dystrophy, including: Cone-rod dystrophy (CORD); Cone dystrophy (COD); Retinal cone dystrophy (RCD)
|
|
ADCY7 |
adenylate cyclase 7 |
- Glucagon signaling in metabolic regulation
- PKA activation
- PKA activation in glucagon signalling
- Adenylate cyclase activating pathway
- Adenylate cyclase inhibitory pathway
- Adenylate cyclase inhibitory pathway
- G alpha (s) signalling events
- G alpha (s) signalling events
- G alpha (i) signalling events
- G alpha (z) signalling events
- G alpha (z) signalling events
- Vasopressin regulates renal water homeostasis via Aquaporins
- Hedgehog 'off' state
- ADORA2B mediated anti-inflammatory cytokines production
- ADORA2B mediated anti-inflammatory cytokines production
- FCGR3A-mediated IL10 synthesis
|
|
|
|
ADD1 |
adducin 1 |
- Caspase-mediated cleavage of cytoskeletal proteins
- XBP1(S) activates chaperone genes
- Miscellaneous transport and binding events
|
|
|
|
ADD2 |
adducin 2 |
- Miscellaneous transport and binding events
|
|
|
|
ADRA2A |
adrenoceptor alpha 2A |
- Adrenoceptors
- Adrenaline signalling through Alpha-2 adrenergic receptor
- Adrenaline,noradrenaline inhibits insulin secretion
- G alpha (i) signalling events
- G alpha (z) signalling events
- Surfactant metabolism
|
- Amphetamine
- Tramadol
- Bethanidine
- Ziprasidone
- Cabergoline
- Ropinirole
- Dihydroergotamine
- Amitriptyline
- Clozapine
- Norepinephrine
- Mirtazapine
- Phenylpropanolamine
- Loxapine
- Pramipexole
- Prochlorperazine
- Dipivefrin
- Prazosin
- Chlorpromazine
- Brimonidine
- Haloperidol
- Nortriptyline
- Amoxapine
- Amoxapine
- Lamotrigine
- Clonidine
- Lisuride
- Guanabenz
- Dexmedetomidine
- Trazodone
- Epinephrine
- Phentolamine
- Ergotamine
- Tizanidine
- Apomorphine
- Paroxetine
- Trimipramine
- Epinastine
- Tolazoline
- Fenoldopam
- Pseudoephedrine
- Benzphetamine
- Phenoxybenzamine
- Maprotiline
- Oxymetazoline
- Apraclonidine
- Methyldopa
- Guanfacine
- Ergoloid mesylate
- Promethazine
- Carvedilol
- Nefazodone
- Desipramine
- Escitalopram
- Pergolide
- Bromocriptine
- Quetiapine
- Aripiprazole
- Paliperidone
- Ephedra sinica root
- Mephentermine
- Yohimbine
- Methotrimeprazine
- 4-Methoxyamphetamine
- Dextroamphetamine
- Metamfetamine
- Periciazine
- Zuclopenthixol
- Celiprolol
- Dronedarone
- Lofexidine
- Epicept NP-1
- Mianserin
- Pizotifen
- Asenapine
- Ocaperidone
- Droxidopa
- Flupirtine
- Esmirtazapine
- Xylometazoline
- Levonordefrin
- Naphazoline
- Lurasidone
- Dosulepin
- Etoperidone
- Lorpiprazole
- Cirazoline
- Moxisylyte
- Aranidipine
- Moxonidine
- Pirlindole
- Pipamperone
- Setiptiline
- Racepinephrine
- Dihydroergocornine
- DL-Methylephedrine
- DL-Methylephedrine
- Xylazine
- Indigotindisulfonic acid
- Rilmenidine
- Tiapride
- Dihydroergocristine
- Aripiprazole lauroxil
|
|
|
ADRB2 |
adrenoceptor beta 2 |
- Adrenoceptors
- G alpha (s) signalling events
- Ub-specific processing proteases
- Cargo recognition for clathrin-mediated endocytosis
- Clathrin-mediated endocytosis
- ADORA2B mediated anti-inflammatory cytokines production
|
- Spermine
- Amphetamine
- Betaxolol
- Bethanidine
- Isoetharine
- Cabergoline
- Metoprolol
- Olanzapine
- Atenolol
- Norepinephrine
- Timolol
- Phenylpropanolamine
- Dipivefrin
- Sotalol
- Carteolol
- Nortriptyline
- Propranolol
- Labetalol
- Bisoprolol
- Epinephrine
- Paroxetine
- Trimipramine
- Cryptenamine
- Orciprenaline
- Dobutamine
- Pseudoephedrine
- Alprenolol
- Ritodrine
- Terbutaline
- Bitolterol
- Phenoxybenzamine
- Salmeterol
- Pindolol
- Formoterol
- Salbutamol
- Ergoloid mesylate
- Isoprenaline
- Arbutamine
- Amiodarone
- Carvedilol
- Desipramine
- Propafenone
- Acebutolol
- Nadolol
- Levobunolol
- Metipranolol
- Aripiprazole
- Arformoterol
- Fenoterol
- Pirbuterol
- Bevantolol
- Penbutolol
- Ephedra sinica root
- Ephedrine
- Mephentermine
- Procaterol
- Clenbuterol
- Bambuterol
- Oxprenolol
- Putrescine
- Spermidine
- Celiprolol
- Nebivolol
- Indacaterol
- Bedoradrine
- NCX 950
- Asenapine
- Droxidopa
- Bufuralol
- Protokylol
- (S)-carazolol
- Bopindolol
- Bupranolol
- Befunolol
- Olodaterol
- Vilanterol
- Arotinolol
- Doxofylline
- Racepinephrine
- Dihydroergocornine
- DL-Methylephedrine
- Etafedrine
- Tulobuterol
- Levosalbutamol
- Dihydroergocristine
|
|
|
AFAP1 |
actin filament associated protein 1 |
|
|
|
|
AKT3 |
AKT serine/threonine kinase 3 |
- Activation of BAD and translocation to mitochondria
- PIP3 activates AKT signaling
- PIP3 activates AKT signaling
- Downregulation of ERBB2:ERBB3 signaling
- AKT phosphorylates targets in the cytosol
- AKT phosphorylates targets in the cytosol
- AKT phosphorylates targets in the nucleus
- Negative regulation of the PI3K/AKT network
- AKT-mediated inactivation of FOXO1A
- CD28 dependent PI3K/Akt signaling
- CTLA4 inhibitory signaling
- G beta:gamma signalling through PI3Kgamma
- VEGFR2 mediated vascular permeability
- TP53 Regulates Metabolic Genes
- Constitutive Signaling by AKT1 E17K in Cancer
- Regulation of TP53 Degradation
- Regulation of TP53 Activity through Acetylation
- Regulation of TP53 Activity through Association with Co-factors
- Cyclin E associated events during G1/S transition
- Cyclin A:Cdk2-associated events at S phase entry
- RAB GEFs exchange GTP for GDP on RABs
- RUNX2 regulates genes involved in cell migration
- Regulation of PTEN stability and activity
- FLT3 Signaling
- Regulation of localization of FOXO transcription factors
- Estrogen-dependent nuclear events downstream of ESR-membrane signaling
|
|
|
|
APP |
amyloid beta precursor protein |
- Platelet degranulation
- ECM proteoglycans
- Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
- G alpha (q) signalling events
- G alpha (i) signalling events
- Lysosome Vesicle Biogenesis
- Formyl peptide receptors bind formyl peptides and many other ligands
- TAK1 activates NFkB by phosphorylation and activation of IKKs complex
- The NLRP3 inflammasome
- Advanced glycosylation endproduct receptor signaling
- Advanced glycosylation endproduct receptor signaling
- Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models
- Post-translational protein phosphorylation
- TRAF6 mediated NF-kB activation
- Insertion of tail-anchored proteins into the endoplasmic reticulum membrane
- Insertion of tail-anchored proteins into the endoplasmic reticulum membrane
- Purinergic signaling in leishmaniasis infection
- Amyloid fiber formation
|
- Deferoxamine
- Aluminium
- Zinc
- L-methionine (R)-S-oxide
- Resveratrol
- Tromethamine
- Phenserine
- Tetrathiomolybdate
- CAD106
- Mito-4509
- Edonerpic
- Dimercaprol
- Copper
- Florbetaben (18F)
- Florbetapir (18F)
- Flutemetamol (18F)
- Zinc acetate
- Aluminium phosphate
- Aluminum acetate
- Zinc chloride
- Zinc sulfate, unspecified form
|
|
|
ART3 |
ADP-ribosyltransferase 3 (inactive) |
- Post-translational modification: synthesis of GPI-anchored proteins
|
|
|
|
BDKRB2 |
bradykinin receptor B2 |
- Peptide ligand-binding receptors
- G alpha (q) signalling events
- G alpha (i) signalling events
|
- Anatibant
- Icatibant
- Labradimil
|
|
|
C1QBP |
complement C1q binding protein |
- Apoptotic factor-mediated response
- Intrinsic Pathway of Fibrin Clot Formation
- Defective Intrinsic Pathway for Apoptosis Due to p14ARF Loss of Function
|
|
|
|
CD34 |
CD34 molecule |
|
|
|
|
CDCP1 |
CUB domain containing protein 1 |
|
|
|
|
CHAT |
choline O-acetyltransferase |
- Synthesis of PC
- Acetylcholine Neurotransmitter Release Cycle
|
|
- Congenital myasthenic syndrome
|
|
CNP |
2',3'-cyclic nucleotide 3' phosphodiesterase |
|
|
|